Hidradenitis Suppurativa | AbbVie | M20-040
Pharmaceutical Company/Sponsor:
AbbVie
Code:
M20-040
Title:
A Phase 2, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Upadacitinib in Adult Subjects With Moderate to Severe Hidradenitis Suppurativa
Type:
Investigational
Phase:
2
Condition/Disease:
Hidradenitis Suppurativa
Intervention(s)/Treatment(s):
Drug: Upadacitinib Placebo Upadacitinib
Status:
Active, Not Recruiting
Link for Additional Information:
